Drugs Made In America Acquisition II Corp. (DMII) bonds
DMIINasdaqBlank ChecksFiscal year ends December 31Also trades as DMIIR, DMIIU
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 16, 2026
$10.23−0.01 (-0.15%)
Close on Nov 18, 2026Market cap $140.15MP/E –Yield –
Debt
Borrowings on the balance sheet, Sep 30, 2026
Drugs Made In America Acquisition II reports no long-term debt line
Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.
Notes and loans outstanding
As tagged in Drugs Made In America Acquisition II's 10-K for the period ended Dec 31, 2024
Drugs Made In America Acquisition II's filings do not break debt down by note
The debt footnote in the annual report has no machine-readable detail for individual notes, so coupons and maturities cannot be listed.
Credit facilities
Revolving credit lines and other committed borrowing capacity
| Facility | Size | Drawn |
|---|---|---|
| Promissory Note {Member] | – | $250.10K |
See a number that looks wrong?